Attached files

file filename
EX-5.1 - OPINION OF FOLEY& LARDNER LLP - MAKO Surgical Corp.mako124747_ex5-1.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  November 14, 2012

  

 

MAKO Surgical corp.

(Exact name of registrant as specified in its charter)

 

Delaware 001-33966 20-1901148
(State or other jurisdiction of
incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)

 

255 Davie Road Fort Lauderdale, Florida 33317

(Address of principal executive offices, including zip code)

 

(954) 927-2044

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 8.01.Other Events.
   

The Company is filing certain exhibits as part of this Current Report on Form 8-K in connection with its filing with the Securities and Exchange Commission of a prospectus supplement, dated November 14, 2012 (the “Prospectus Supplement”), relating to the resale from time to time by the selling stockholders named therein of 490,471 shares of the Company’s common stock, par value $0.001 per share (the “Offering Shares”). The Prospectus Supplement forms a part of, and the sale of Offering Shares is registered under, the Company’s Registration Statement on Form S-3 (Registration No. 333-181277). See “Item 9.01. Financial Statements and Exhibits.”

 

Item 9.01.Financial Statements and Exhibits.
   
(a)Not applicable.

 

(b)Not applicable.

 

(c)Not applicable.

 

(d)Exhibits. The following exhibits are being filed herewith:

 

(5.1)Opinion of Foley & Lardner LLP, dated November 14, 2012.

 

(23.1)Consent of Foley & Lardner LLP (contained in Exhibit (5.1) hereto).

 

 

 

 

 

 

 

-2-
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  MAKO SURGICAL CORP.
     
     
Date:  November 14, 2012 By: /s/ Menashe R. Frank
    Menashe R. Frank
Senior Vice President,
  General Counsel and Secretary

 

 

 

 

 

 

 

 

-3-
 

MAKO SURGICAL CORP.

 

Exhibit Index to Current Report on Form 8-K

Dated November 14, 2012

Exhibit

Number

 

(5.1)Opinion of Foley & Lardner LLP, dated November 14, 2012.

 

(23.1)Consent of Foley & Lardner LLP (contained in Exhibit (5.1) hereto).

 

 

 

 

 

 

 

 

 

 

 

-4-